The global spinal cord stimulation market will grow at a compound annual growth rate of 9.2 percent through 2021, based on a Market Data Forecast report, according to medGadget.
Here are five observations:
1. In North America, an increasing adult population and demand for minimally invasive surgeries will drive the SCS market.
2. Therapy costliness and hindering regulations will serve as obstacles to the market's growth.
3. North America dominates the global market because of the prominent manufacturers in the area.
4. In the North American market, hospitals account for 75 percent of the SCS end-user market.
5. Key market players include Medtronic, Nevro, St. Jude Medical, Greatbatch and Stimwave.